Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units.

Fecha de publicación: Fecha Ahead of Print:

Autores de IDIVAL

Autores ajenos al IDIVAL

  • Vidal-Cortés P
  • Díaz Santos E
  • Aguilar Alonso E
  • Amezaga Menéndez R
  • Bodí MA
  • Bordejé Laguna ML
  • Garnacho Montero J
  • García Sánchez M
  • Martín-Loeches I
  • Ochagavía Calvo A
  • Ramírez Galleymore P
  • Alcántara Carmona S
  • Andaluz Ojeda D
  • Badallo Arébalo O
  • Barrasa González H
  • Borges Sa M
  • Castellanos-Ortega Á
  • Estella Á
  • Ferrer Roca R
  • Fraile Gutiérrez V
  • Fuset Cabanes M
  • Giménez-Esparza Vich C
  • González Iglesias C
  • Hernández-Tejedor A
  • Igeño Cano JC
  • Iglesias Posadilla D
  • Jiménez Rivera JJ
  • Llanos Jorge C
  • Llompart-Pou JA
  • López Camps V
  • Lorencio Cárdenas C
  • Marcos Neira P
  • Martín Delgado MC
  • Martín-Macho González M
  • Martín Villén L
  • Nuvials Casals X
  • Ortiz Suñer A
  • Quintana Díaz M
  • Rascado Sedes P
  • Recuerda Núñez M
  • Del Río Carbajo L
  • Rodríguez Aguirregabiria M
  • Rodríguez Oviedo A
  • Seijas Betolaza I
  • Soriano Cuesta C
  • Vera Ching C
  • Vidal González Á
  • Zapata Fenor L
  • Zaragoza Crespo R

Unidades

Abstract

The COVID-19 pandemic has led to the admission of a high number of patients to the ICU, generally due to severe respiratory failure. Since the appearance of the first cases of SARS-CoV-2 infection, at the end of 2019, in China, a huge number of treatment recommendations for this entity have been published, not always supported by sufficient scientific evidence or with methodological rigor necessary. Thanks to the efforts of different groups of researchers, we currently have the results of clinical trials, and other types of studies, of higher quality. We consider it necessary to create a document that includes recommendations that collect this evidence regarding the diagnosis and treatment of COVID-19, but also aspects that other guidelines have not considered and that we consider essential in the management of critical patients with COVID-19. For this, a drafting committee has been created, made up of members of the SEMICYUC Working Groups more directly related to different specific aspects of the management of these patients.

Copyright © 2021 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
2173-5727, 2173-5727

Medicina Intensiva  

Tipo:
Practice Guideline
Páginas:
81-89
PubMed:
34903475
Enlace a otro recurso:
www.sciencedirect.com

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • COVID-19, COVID-19 Testing, COVID-19 drug treatment, Critical care, Críticos, Intensive Care Units, Prueba de COVID-19, SARS-CoV-2, Tratamiento farmacológico de la COVID-19, Unidades de Cuidados Intensivos

Compartir